Maternal Phenylketonuria syndrome: Studies in mice suggest a potential approach to a continuing problem.

CONCLUSION: PAL treatment reduced maternal PKU syndrome severity in mice and may have potential for human PKU therapy.Pediatric Research accepted article preview online, 21 December 2017. doi:10.1038/pr.2017.323. PMID: 29278642 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29278642?dopt=Abstract

Source: Pediatric Research - December 21, 2017 Category: Pediatrics Authors: Zeile WL, McCune HC, Musson DG, O'Donnell B, O'Neill CA, Tsuruda LS, Zori RT, Laipis PJ Tags: Pediatr Res Source Type: research